ArticleFrontiers in endocrinology2026
Comparison of euploidy rates between progestin-primed ovarian stimulation and GnRH antagonist protocols: a single-center study in a mixed-ethnicity population.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To compare the euploidy rate between ovulation suppression protocols using PPOS and GnRH-ant, and to evaluate possible variables associated with euploidy rate such as age, BMI, infertility duration, treatment-related factors, and semen parameters, in a genetically admixed Brazilian population underrepresented in reproductive medicine research. Design: This was a retrospective non-inferiority case-control study including 268 IVF cycles, conducted between 2021 and 2022. Subjects: A total of 268 Exposure: Patients underwent controlled ovarian stimulation using either progestin-primed ovarian stimulation (PPOS) or GnRH antagonist (GnRH-ant) protocols. Main outcome measures: The primary outcome was the euploidy rate in PPOS and GnRH-ant groups. Results: No significant differences were observed in euploidy rate between the PPOS and GnRH-ant groups (25.9% vs. 27.5%; p = 0.865; r = 0.01). In the adjusted analysis, stimulation protocol was not significantly associated with euploidy rate (coefficient = 3.38; 95% CI: -14.26 to 16.03), whereas maternal age remained significantly and negatively associated with the outcome (coefficient = -7.83; 95% CI: -11.85 to -3.81). Fertilization rate was higher in the GnRH-ant group (p = 0.004), but this did not affect embryo formation or euploidy outcomes. Paternal age and semen parameters were not significantly associated with euploidy. Conclusion: According to the prespecified criterion, PPOS met the formal criterion for non-inferiority in relation to GnRH-ant regarding euploidy rate, although with limited margin. These findings support PPOS as a viable option in freeze-all/PGT-A cycles, but they should be interpreted with caution given the retrospective design and baseline differences between groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.